Abstract
Formal retraction notice of article entitled Current Review of Ramosetron in the Prevention Of Postoperative Nausea and Vomiting (Curr Drug Saf. 2011 Apr;6(2):122-7) by Dr Y. Fujii.
This article is being retracted as a result of:
Failure of Dr. Fijii's institution as well as of himself to rationalize the legitimacy of the study and/or its data as stipulated in request by the Editors-in-Chief of the journals extended on April 9, 2012.
Current Drug Safety
Title:Retraction Notice: Current Review of Ramosetron in the Prevention of Postoperative Nausea and Vomiting
Volume: 6 Issue: 2
Author(s): Yoshitaka Fujii
Affiliation:
Abstract: Formal retraction notice of article entitled Current Review of Ramosetron in the Prevention Of Postoperative Nausea and Vomiting (Curr Drug Saf. 2011 Apr;6(2):122-7) by Dr Y. Fujii.
This article is being retracted as a result of:
Failure of Dr. Fijii's institution as well as of himself to rationalize the legitimacy of the study and/or its data as stipulated in request by the Editors-in-Chief of the journals extended on April 9, 2012.
Export Options
About this article
Cite this article as:
Fujii Yoshitaka, Retraction Notice: Current Review of Ramosetron in the Prevention of Postoperative Nausea and Vomiting, Current Drug Safety 2011; 6 (2) . https://dx.doi.org/10.2174/157488611795684640
DOI https://dx.doi.org/10.2174/157488611795684640 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Angiogenesis in Ischemic Heart Disease: Gene or Recombinant Vascular Growth Factor Protein Therapy?
Current Gene Therapy Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Efficacy and Cardiovascular Safety of SGLT2 Inhibitors
Current Drug Safety Measurement of Hemodynamic Parameters and Antidepressant Activity in Hypertensive Rats Following Two Weeks Consumption of <i>Acacia Tortilis</i> Leaves Extract
The Natural Products Journal Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Triptan-Induced Torsades de Pointes and Ventricular Fibrillation Cardiac Arrest: Case Report and Review of the Literature
Current Drug Safety Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Current Vascular Pharmacology Improvement in Hypertension Management with Pharmacological and Non- Pharmacological Approaches: Current Perspectives
Current Pharmaceutical Design Patent Selections
Recent Patents on Food, Nutrition & Agriculture Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Anti-Cancer Agents in Medicinal Chemistry Acidic Ionic Liquids Catalyzed One-Pot and Three-Component Synthesis of Octahydroquinazolin-2,5-dione Derivatives Under Ambient Conditions
Letters in Organic Chemistry The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Metabolic Profile of Flunitrazepam: Clinical and Forensic Toxicological Aspects
Drug Metabolism Letters Erythropoietin in Stroke Therapy: Friend or Foe
Current Medicinal Chemistry <i>Achillea millefolium</i> E.Mey: Phytochemistry and Pharmacological Profile
Current Traditional Medicine Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Clozapine Safety, 35 Years Later
Current Drug Safety Antidiabetic Potential of Fabaceae Family: An Overview
Current Nutrition & Food Science Structure-Activity Relationships of KATP Channel Openers
Current Topics in Medicinal Chemistry